Aprea Therapeutics Inc expected to post a loss of $2.60 a share - Earnings Preview

Aprea Therapeutics

10/03/2023 11:19

* Aprea Therapeutics Inc  APRE.OQ   APRE.O  is expected
to show no
change in quarterly revenue when it reports  results on March 13
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Aprea Therapeutics
Inc is
for a loss of $2.60 per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Aprea
Therapeutics Inc is $60​, above​ its last closing price
of $5.08. ​​​

This summary was machine generated March 10 at 11:19 GMT.  All
figures in US dollars  unless otherwise stated